Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.
about
Functional characterization of excision repair and RecA-dependent recombinational DNA repair in Campylobacter jejuniGenetic detection of quinolone resistance in Haemophilus parainfluenzae: Mutations in the quinolone resistance-determining regions of gyrA and parC.Novel Ser79Leu and Ser81Ile substitutions in the quinolone resistance-determining regions of ParC topoisomerase IV and GyrA DNA gyrase subunits from recent fluoroquinolone-resistant Streptococcus pneumoniae clinical isolatesReduced levofloxacin susceptibility and tetracycline resistance in a clinical isolate of Haemophilus quentini identified by 16S rRNA sequencing.Reduced levofloxacin susceptibility in clinical respiratory isolates of Haemophilus influenzae is not yet associated with mutations in the DNA gyrase and topoisomerase II genes in Korea.Molecular characterization of fluoroquinolone resistance in nontypeable Haemophilus influenzae clinical isolates.Decreased levofloxacin susceptibility in Haemophilus influenzae in children, Hong Kong.Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children.Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolAntimicrobial resistance in cystic fibrosis isolates of Haemophilus influenzae.Bactericidal activity of besifloxacin against staphylococci, Streptococcus pneumoniae and Haemophilus influenzae.Melting curve analysis for rapid detection of topoisomerase gene mutations in Haemophilus influenzae.Fluoroquinolone resistance in Haemophilus influenzae is associated with hypermutability.
P2860
Q28484957-6556F5C7-F9AA-47DB-B6B5-474280846D28Q33780017-A95311BB-6E7E-4E4E-9DA6-A189689BF593Q33836603-1877CDE9-9F67-4CDD-9CEB-808BE9B65B60Q34073506-46C7D53C-594A-4B91-A30F-A454D1FD6D8DQ34474574-580EA6F9-DF96-42BB-A395-E13BBE147AB3Q34922753-9D86AED5-B8DB-467A-9E85-B7632A0BC74EQ35895935-5D31F5B3-014C-40DD-9EED-6FC203D7BA1DQ36423756-E1EA6DBA-D835-4435-AEC2-9FCF5DD17FDDQ37392760-FE194F6E-09F3-4436-BF88-9371275FC926Q40674040-DA4AB6B7-5023-441D-B0DA-70AB85F13645Q40953254-18AB9359-48BF-4A42-B98F-16E9913C20B6Q41873346-80529C69-774C-48A8-8E9E-117D16FA1DA8Q41991607-7F980940-0FDC-41C0-9E8D-52CB7EE687C4
P2860
Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to GyrA and ParC mutations.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Laboratory detection of Haemop ...... ue to GyrA and ParC mutations.
@en
type
label
Laboratory detection of Haemop ...... ue to GyrA and ParC mutations.
@en
prefLabel
Laboratory detection of Haemop ...... ue to GyrA and ParC mutations.
@en
P2093
P2860
P1476
Laboratory detection of Haemop ...... ue to GyrA and ParC mutations.
@en
P2093
Belén Aracil
Federico Román
José Campos
María Pérez-Vázquez
Rafael Cantón
P2860
P304
P356
10.1128/JCM.42.3.1185-1191.2004
P407
P577
2004-03-01T00:00:00Z